An Empire Strykes Back

The summer of 2006 did not bring good news for management at orthopedic-product maker Stryker (NYSE: SYK  ) . The company received a subpoena from the Department of Justice amid industrywide allegations of kickbacks and anti-competitive business practices. Cool-headed investors who decided to pick up shares of Stryker during this time have since been handsomely rewarded.

The stock has risen more than 70% since then, and the good news for Stryker continues to roll in. Yesterday, the company reported an impressive third quarter, including a 22.2% increase in quarterly earnings per share from continuing operations, as well as an 18% surge in Q3 net sales.

The company saw strong results from both of its major business segments. Stryker continues to cash in on an aging baby boomer generation, as witnessed in its orthopedic-implant business, where revenue grew by 15.4% versus the year-ago quarter. Stryker's MedSurg equipment business also experienced vibrant results, with a 22% increase in sales.

Stryker has been the lead dog among major players in orthopedic implants. However, Smith & Nephew (NYSE: SNN  ) has risen about 20% year to date, and Zimmer Holdings (NYSE: ZMH  ) , which reports its earnings next week, is expecting full-year earnings growth of nearly 19%. Further good news for the industry came last month, when Stryker, Zimmer, Smith & Nephew, and Johnson & Johnson (NYSE: JNJ  ) all were able to resolve their respective investigations pending with the Justice Department.

With the Justice investigation out of the way, and management expecting adjusted full-year results to include a 20% increase in EPS from continuing operations, Stryker continues to remain an attractive investment option for Fools who want a consistent performer for the long haul.

For more takes on how to make the big bones check out:

Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 538743, ~/Articles/ArticleHandler.aspx, 10/25/2016 1:04:14 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:01 PM
SYK $114.73 Up +1.02 +0.90%
Stryker CAPS Rating: *****
JNJ $113.61 Up +0.17 +0.15%
Johnson and Johnso… CAPS Rating: ****
SNN $30.13 Down -0.27 -0.89%
Smith and Nephew CAPS Rating: ****
ZMH.DL $0.00 Down +0.00 +0.00%
Zimmer Holdings CAPS Rating: ****